Publications by authors named "Elif Kaymaz"

Article Synopsis
  • - The study aimed to assess the occurrence of new symptoms (de novo manifestations) in Behçet syndrome patients undergoing adalimumab treatment over a 15-year period.
  • - Out of 335 patients, only 4% experienced new symptoms, including various major organ involvements such as vascular issues and arthritis, prompting adjustments in their treatment regimens.
  • - Overall, de novo manifestations are rare in patients treated with adalimumab, with a notable absence of posterior uveitis in this group.
View Article and Find Full Text PDF